CN101342164B - 苯扎贝特控释制剂及其制备方法 - Google Patents
苯扎贝特控释制剂及其制备方法 Download PDFInfo
- Publication number
- CN101342164B CN101342164B CN2007101433749A CN200710143374A CN101342164B CN 101342164 B CN101342164 B CN 101342164B CN 2007101433749 A CN2007101433749 A CN 2007101433749A CN 200710143374 A CN200710143374 A CN 200710143374A CN 101342164 B CN101342164 B CN 101342164B
- Authority
- CN
- China
- Prior art keywords
- bezafibrate
- controlled release
- preparation
- release preparation
- coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- IIBYAHWJQTYFKB-UHFFFAOYSA-N bezafibrate Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CCNC(=O)C1=CC=C(Cl)C=C1 IIBYAHWJQTYFKB-UHFFFAOYSA-N 0.000 title claims abstract description 113
- 229960000516 bezafibrate Drugs 0.000 title claims abstract description 112
- 238000002360 preparation method Methods 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000013270 controlled release Methods 0.000 title description 10
- 238000009472 formulation Methods 0.000 title description 6
- 239000003405 delayed action preparation Substances 0.000 claims abstract description 48
- 239000004014 plasticizer Substances 0.000 claims abstract description 9
- 238000009501 film coating Methods 0.000 claims abstract description 8
- 229920002301 cellulose acetate Polymers 0.000 claims abstract description 6
- DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000001856 Ethyl cellulose Substances 0.000 claims abstract description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229920006218 cellulose propionate Polymers 0.000 claims abstract description 4
- 229920001249 ethyl cellulose Polymers 0.000 claims abstract description 4
- 235000019325 ethyl cellulose Nutrition 0.000 claims abstract description 4
- 229920000573 polyethylene Polymers 0.000 claims abstract description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 4
- 238000000576 coating method Methods 0.000 claims description 57
- 239000011248 coating agent Substances 0.000 claims description 53
- 239000010410 layer Substances 0.000 claims description 50
- 239000003814 drug Substances 0.000 claims description 28
- 230000003204 osmotic effect Effects 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 22
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 22
- 239000012528 membrane Substances 0.000 claims description 20
- 239000000314 lubricant Substances 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 17
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 16
- 230000035699 permeability Effects 0.000 claims description 15
- -1 Merlon Polymers 0.000 claims description 14
- 239000008187 granular material Substances 0.000 claims description 13
- 239000002562 thickening agent Substances 0.000 claims description 13
- 239000012792 core layer Substances 0.000 claims description 12
- 239000004094 surface-active agent Substances 0.000 claims description 12
- 235000019359 magnesium stearate Nutrition 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 9
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 9
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 9
- 229960003943 hypromellose Drugs 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 239000007779 soft material Substances 0.000 claims description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 8
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 8
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 8
- 239000011230 binding agent Substances 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 5
- 235000011147 magnesium chloride Nutrition 0.000 claims description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 5
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000001103 potassium chloride Substances 0.000 claims description 5
- 235000011164 potassium chloride Nutrition 0.000 claims description 5
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 5
- 229910052939 potassium sulfate Inorganic materials 0.000 claims description 5
- 235000011151 potassium sulphates Nutrition 0.000 claims description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 5
- 235000011152 sodium sulphate Nutrition 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 229920000136 polysorbate Polymers 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 239000010409 thin film Substances 0.000 claims description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims description 2
- 206010013786 Dry skin Diseases 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 239000007888 film coating Substances 0.000 abstract 5
- 239000002861 polymer material Substances 0.000 abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 229920000515 polycarbonate Polymers 0.000 abstract 1
- 239000004417 polycarbonate Substances 0.000 abstract 1
- 239000011148 porous material Substances 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 2
- 239000003361 porogen Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 239000003741 agents affecting lipid metabolism Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004648 butanoic acid derivatives Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N o-dicarboxybenzene Natural products OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
质量比例 | 醋酸纤维素 | 乙基纤维素 | 丙酸纤维素 | 聚碳酸酯 | 聚乙烯 | 聚乙烯醇 | 甘油三酯 | 邻苯二甲酸酯 | 聚乙二醇 |
实施例1 | 40 | 0 | 0 | 40 | 0 | 0 | 20 | 0 | 0 |
实施例2 | 0 | 20 | 0 | 0 | 20 | 30 | 10 | 10 | 10 |
实施例3 | 5 | 15 | 10 | 10 | 20 | 0 | 0 | 20 | 20 |
实施例4 | 0 | 0 | 65 | 0 | 0 | 0 | 25 | 10 | 0 |
实施例5 | 0 | 50 | 0 | 0 | 25 | 0 | 0 | 25 | 0 |
实施例6 | 66.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.3 |
质量比例 | 实施例7 | 实施例8 | 实施例9 | 实施例10 | 实施例11 | 实施例12 | 实施例13 | 实施例14 | 实施例15 |
苯扎贝特 | 50 | 60 | 70 | 60 | 65 | 55 | 50 | 70 | 60 |
碳酸钠 | 0 | 0 | 2 | 0 | 2 | 0 | 1 | 3 | 3 |
碳酸氢钠 | 0 | 4 | 0 | 3 | 2 | 2 | 0 | 2 | 0 |
枸橼酸钠 | 5 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 0 |
十二烷基硫酸钠 | 8 | 5 | 4 | 0 | 0 | 0 | 3 | 5 | 7.5 |
吐温 | 0 | 1 | 4 | 3 | 6 | 8 | 0 | 0 | 0 |
聚氧乙烯 | 6 | 3 | 9 | 10 | 15 | 0 | 0 | 0 | 12 |
羟丙甲纤维素 | 6 | 6 | 0 | 5 | 0 | 15 | 12 | 9 | 0 |
氯化钠 | 0 | 0 | 0 | 0 | 0 | 6 | 5 | 3 | 15 |
氯化钾 | 15 | 0 | 0 | 0 | 0 | 5 | 0 | 3 | 0 |
氯化镁 | 0 | 18 | 0 | 0 | 10 | 0 | 5 | 3 | 0 |
硫酸钠 | 0 | 0 | 11 | 0 | 5 | 0 | 5 | 3 | 0 |
硫酸钾 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 3 | 0 |
硫酸镁 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 3 | 0 |
硬脂酸镁 | 3 | 2 | 1 | 1.5 | 2.5 | 1 | 2 | 3 | 1 |
质量比例 | 实施例16 | 实施例17 | 实施例18 | 实施例19 | 实施例20 | 实施例21 | 实施例22 | 实施例23 | 实施例24 |
苯扎贝特1 | 45 | 46 | 47 | 48 | 49 | 50 | 50 | 45 | 48 |
碳酸钠 | 0 | 0 | 2 | 0 | 2 | 0 | 1 | 3 | 3 |
碳酸氢钠 | 0 | 4 | 0 | 3 | 2 | 2 | 0 | 2 | 0 |
枸橼酸钠 | 5 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 0 |
十二烷基硫酸钠 | 8 | 5 | 4 | 0 | 0 | 0 | 3 | 5 | 7.5 |
吐温 | 0 | 1 | 4 | 3 | 6 | 8 | 0 | 0 | 0 |
氯化钠1 | 0 | 0 | 0 | 0 | 0 | 5 | 4 | 2.5 | 12 |
氯化钾1 | 12 | 0 | 0 | 0 | 0 | 4 | 0 | 2.5 | 0 |
氯化镁1 | 0 | 15 | 0 | 0 | 9 | 0 | 4 | 2.5 | 0 |
硫酸钠1 | 0 | 0 | 9 | 0 | 3 | 0 | 4 | 2.5 | 0 |
硫酸钾1 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 2.5 | 0 |
硫酸镁1 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 2.5 | 0 |
羟丙甲纤维素1 | 1 | 0 | 0 | 0.3 | 0.04 | 0.3 | 0.5 | 0 | 0.5 |
乙醇 | 0 | 0.1 | 0 | 0.3 | 0.03 | 0.2 | 0 | 0.05 | 0.4 |
乙醇和水溶液 | 0 | 0 | 0.5 | 0.4 | 0.03 | 0 | 0.5 | 0.05 | 0 |
硬脂酸镁1 | 1 | 0.6 | 0.3 | 0.5 | 0.8 | 0.3 | 0.7 | 1 | 0.3 |
聚氧乙烯 | 6 | 3 | 9 | 10 | 15 | 0 | 0 | 0 | 12 |
羟丙甲纤维素2 | 6 | 6 | 0 | 5 | 0 | 15 | 12 | 9 | 0 |
氯化钠2 | 0 | 0 | 0 | 0 | 0 | 0.5 | 1 | 0.5 | 2.5 |
氯化钾2 | 2.5 | 0 | 0 | 0 | 0 | 0.5 | 0 | 1 | 0 |
氯化镁2 | 0 | 4 | 0 | 0 | 1.5 | 0 | 1 | 1 | 0 |
硫酸钠2 | 0 | 0 | 1 | 0 | 1 | 0 | 0.5 | 0.5 | 0 |
硫酸钾2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0.5 | 0 |
硫酸镁2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0.5 | 0 |
硬脂酸镁2 | 3 | 2 | 1 | 1.5 | 2.5 | 1 | 2 | 3 | 1 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101433749A CN101342164B (zh) | 2007-08-21 | 2007-08-21 | 苯扎贝特控释制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101433749A CN101342164B (zh) | 2007-08-21 | 2007-08-21 | 苯扎贝特控释制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101342164A CN101342164A (zh) | 2009-01-14 |
CN101342164B true CN101342164B (zh) | 2011-04-20 |
Family
ID=40244357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101433749A Active CN101342164B (zh) | 2007-08-21 | 2007-08-21 | 苯扎贝特控释制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101342164B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102462675B (zh) * | 2010-11-09 | 2015-08-19 | 北京以岭生物工程技术有限公司 | 一种苯扎贝特缓释片及其制备方法 |
CN103040798A (zh) * | 2011-11-08 | 2013-04-17 | 深圳信立泰药业股份有限公司 | 一种苯扎贝特缓释药物组合物 |
CN103908437B (zh) * | 2013-01-04 | 2018-04-27 | 江苏天士力帝益药业有限公司 | 一种苯扎贝特缓释制剂及其制备方法 |
CN113559077B (zh) * | 2020-04-29 | 2023-11-14 | 江苏天士力帝益药业有限公司 | 一种苯扎贝特缓释片及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840330A (en) * | 1990-07-02 | 1998-11-24 | Boehringer Mannhelm Gmbh | Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained |
CN1290160A (zh) * | 1998-02-12 | 2001-04-04 | 默克专利股份有限公司 | 含有二甲双胍和贝特联合的药物组合物及其在制备降低高血糖药物中的应用 |
CN101120931A (zh) * | 2006-08-07 | 2008-02-13 | 珠海天翼医药技术开发有限公司 | 一种苯扎贝特缓释组合物 |
-
2007
- 2007-08-21 CN CN2007101433749A patent/CN101342164B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840330A (en) * | 1990-07-02 | 1998-11-24 | Boehringer Mannhelm Gmbh | Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained |
CN1290160A (zh) * | 1998-02-12 | 2001-04-04 | 默克专利股份有限公司 | 含有二甲双胍和贝特联合的药物组合物及其在制备降低高血糖药物中的应用 |
CN101120931A (zh) * | 2006-08-07 | 2008-02-13 | 珠海天翼医药技术开发有限公司 | 一种苯扎贝特缓释组合物 |
Non-Patent Citations (2)
Title |
---|
JP特开平10-130142A 1998.05.19 |
JP特开平10-167962A 1998.06.23 |
Also Published As
Publication number | Publication date |
---|---|
CN101342164A (zh) | 2009-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20090038392A (ko) | 방출 증진제를 포함하는 삼투 약물 전달 시스템 | |
CN100393302C (zh) | 难溶性药物组合物渗透泵控释制剂 | |
CN101342164B (zh) | 苯扎贝特控释制剂及其制备方法 | |
CN103239719A (zh) | 二甲双胍复方药物组合物及其制备方法 | |
CN102048701A (zh) | 一种匹伐他汀钙肠溶缓释微丸制剂及其制备方法 | |
CN104414992B (zh) | 格列吡嗪渗透泵控释片及其制备方法 | |
CN102247370B (zh) | 复方瑞格列奈-盐酸二甲双胍的控释制剂 | |
CN102349880B (zh) | 伊拉地平控释片及其制备方法 | |
CN103550183A (zh) | 一种盐酸曲美他嗪渗透泵控释片及其制备方法 | |
CN101342151A (zh) | 单硝酸异山梨酯渗透泵型控释制剂及其制备方法 | |
CN102091052B (zh) | 双环醇双层渗透泵控释片剂及其制备方法 | |
CN103284974B (zh) | 盐酸苯环壬酯双层渗透泵控释片及其制备方法 | |
CN102525991A (zh) | 一种含有盐酸吡格列酮和盐酸二甲双胍的复方制剂及其制备方法 | |
CN102670545A (zh) | 卡维地洛双层渗透泵型控释制剂及其制备方法 | |
CN114681420A (zh) | 一种间苯三酚控释片及其制备方法 | |
CN102552205B (zh) | 一种枸橼酸钾控释片制剂及其制备方法 | |
CN104887639B (zh) | 盐酸曲美他嗪单层渗透泵控释片及制备方法 | |
CN100413491C (zh) | 一种难溶性药物的控释制剂 | |
CN101385733A (zh) | 一种复方甘草酸苷缓释制剂 | |
CN103181886A (zh) | 一种青蒿素或其衍生物的缓释制剂及其制备方法 | |
CN1332668C (zh) | 千金藤素缓释制剂 | |
CN101690723B (zh) | 琥珀酸舒马普坦复方制剂及其制备方法 | |
CN102144985A (zh) | 一种氯化钾单室渗透泵控释片及其制备方法 | |
CN102485219A (zh) | 盐酸地尔硫卓延迟释放双层渗透泵控释片及其制备方法 | |
CN102038661A (zh) | 齐墩果酸渗透泵片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20081121 Address after: A Road West, hi tech Zone, Fuxin economic and Technological Development Zone, Liaoning Applicant after: Fuxin Xianhe Pharmaceutical Co., Ltd. Address before: A Road West, hi tech Zone, Fuxin economic and Technological Development Zone, Liaoning Applicant before: Xu Liyuan |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: FUXIN CITY CRANE PHARMACEUTICAL CO. Free format text: FORMER OWNER: XU LIYUAN Effective date: 20081121 |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN TASLY (LIAONING) PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: FUXIN XIANHE PHARMACEUTICAL CO., LTD. Effective date: 20111209 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 123000 FUXIN, LIAONING PROVINCE TO: 12300 FUXIN, LIAONING PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20111209 Address after: Twelve thousand and three hundred A Road West, hi tech Zone, Fuxin economic and Technological Development Zone, Liaoning Patentee after: Tianjin Tasly Pharmaceutical Co., Ltd. (Liaoning) Address before: 123000 hi tech park, Fuxin economic and Technological Development Zone, Liaoning, A Patentee before: Fuxin Xianhe Pharmaceutical Co., Ltd. |